iwNHL 2015: TGR-1202, novel PI3K delta inhibitor, for hematological malignancies

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Owen A. O'Connor, MD, PhD, of Columbia University, New York, NY, discusses TGR-1202, a novel phosphoinositide 3-kinase (PI3K... Author: VJHemOnc Added: 11/22/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts